What Makes Intellia Therapeutics (NTLA) an Interesting Investment? [Yahoo! Finance]
Intellia Therapeutics, Inc. (NTLA)
Last intellia therapeutics, inc. earnings: 2/27 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.intelliatx.com/investor-overview
Company Research
Source: Yahoo! Finance
Fund”. A copy of the letter can be downloaded here . The fund's investor class returned 30.9% in the September quarter compared to 7.3% for the benchmark MSCI World Index, including reinvested net income, and 5.5% for the Average Global Equity Fund. The fund's investment philosophy is independent of benchmark considerations, so the portfolios typically deviate from the benchmark World Index. Additionally, please review the fund's top five holdings to see its leading picks in 2025. In its third-quarter 2025 investor letter, Contrarius Global Equity Fund highlighted stocks such as Intellia Therapeutics, Inc. (NASDAQ: NTLA ). Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a clinical-stage gene editing company. The one-month return of Intellia Therapeutics, Inc. (NASDAQ:NTLA) was 12.84%, and its shares lost 21.61% of their value over the last 52 weeks. On December 29, 2025, Intellia Therapeutics, Inc. (NASDAQ:NTLA) stock closed at $9.14 per share, with a market capitalization of $1.059 bi
Show less
Read more
Impact Snapshot
Event Time:
NTLA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTLA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTLA alerts
High impacting Intellia Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
NTLA
News
- Intellia CEO Sells $314K in Stock While Holding Over 1 Million Shares [Yahoo! Finance]Yahoo! Finance
- Fred Cohen Buys 303% More Intellia Therapeutics Shares [Yahoo! Finance]Yahoo! Finance
- Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Intellia Stock Declines Around 55% in 3 Months: Here's Why [Yahoo! Finance]Yahoo! Finance
NTLA
Earnings
- 11/6/25 - Beat
NTLA
Sec Filings
- 1/9/26 - Form 8-K
- 1/7/26 - Form 4
- 1/7/26 - Form 4
- NTLA's page on the SEC website